𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neurologic dysfunction in patients treated for small cell carcinoma of the lung: A clinical and radiological study


Book ID
122953886
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
90 KB
Volume
3
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II clinical study of mAMSA in sm
✍ P. J. Dady; A. -P. Sappino; A. Rudd; I. E. Smith πŸ“‚ Article πŸ“… 1981 πŸ› Springer 🌐 English βš– 167 KB

Thirteen patients with small cell carcinoma of the bronchus that had become resistant to conventional chemotherapy were given 4'-(9-acridinylamino)methanesulphon-m-anisidide (mAMSA) at a dose of 90 or 120 mg/m2 at 3-week intervals. Twenty percent of the courses at 90 mg/m2 produced marked myelosuppr

Neurologic disorders in 203 consecutive
✍ Ansel G. M. van Oosterhout; Marjan van de Pol; Guul P. M. ten Velde; Albert Twij πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

## BACKGROUND. Neurologic complications of small cell lung cancer (sC1.C) are manifold. The incidence and course of the various metastatic and nonmetastatic neurologic disorders were studied prospectively in a cohort of SCLC patients. ## METHODS. The 203 patients underwent neurologic examinations

Long-Term survival of patients treated w
✍ Luigi Corti; Lamberto Toniolo; Caterina Boso; Flavio Colaut; Davide Fiore; Pier- πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 159 KB

## Abstract ## Purpose The role of photodynamic therapy (PDT) in the treatment of small cancers has been established in several clinical studies. Here, we report on the efficacy of PDT for early inoperable or recurrent non‐small‐cell lung cancer (NSCLC). ## Methods and Materials From June 1989 t